Form 4 for CGON CG Oncology, Inc.
Accepted 2026-06-16 17:07:09 ET · period of report 2026-06-15 · accession 0001684531-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-06-16 17:07 | 2026-06-15 | CGON | Mulay James | Dir | M - OptEx | $9.64 | +1,964 | 1,310 | New | +$18.9K |
| DMT | 2026-06-16 17:07 | 2026-06-15 | CGON | Mulay James | Dir | S - Sale+OE | $60.12 | -1,964 | 0 | -100% | -$118.1K |
| DMT | 2026-06-16 17:07 | 2026-06-15 | CGON | Mulay James | Dir | M - OptEx | $0.00 | -1,964 | 2,620 | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-15 | M | A | 654 | $3.72 | 654 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-15 | S | D | 654 | $60.12 | 0 | D | — | — | (F1) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2026. |
| 3 | Common | Common Stock | 2026-06-15 | M | A | 1,310 | $12.59 | 1,310 | D | — | — | |
| 4 | Common | Common Stock | 2026-06-15 | S | D | 1,310 | $60.12 | 0 | D | — | — | (F1) The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2026. |
| 5 | Derivative | Director Stock Option (right to buy) | 2026-06-15 | M | D | 654 | $0.00 | 0 | D | $3.72 · — to 2033-06-13 | 654 Common Stock | (F2) The stock option vested in 36 substantially equal monthly installments beginning on July 14, 2023. |
| 6 | Derivative | Director Stock Option (right to buy) | 2026-06-15 | M | D | 1,310 | $0.00 | 2,620 | D | $12.59 · — to 2033-12-12 | 1,310 Common Stock | (F3) The stock option vests in 36 substantially equal monthly installments beginning on January 13, 2024. |